Selected research
Industry Research
Hydrocodone Bitartrate Industry Research Report 2026
Market perspective
The global Hydrocodone Bitartrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydrocodone Bitartrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydrocodone Bitartrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydrocodone Bitartrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydrocodone Bitartrate include Cambrex, CNPIC, Fagron, Freedom Pharmaceuticals, Johnson Matthey, Letco Medical, Noramco, Sun Pharma(Chattem Chemicals) and Temad, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydrocodone Bitartrate market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydrocodone Bitartrate Market by Company
Cambrex
CNPIC
Fagron
Freedom Pharmaceuticals
Johnson Matthey
Letco Medical
Noramco
Sun Pharma(Chattem Chemicals)
Temad
Hydrocodone Bitartrate Segment by Type
Below 98%
Above 98%
Hydrocodone Bitartrate Segment by Application
Hydrocodone Bitartrate Oral Solutions
Hydrocodone Bitartrate Extended-Release Tablets
Hydrocodone Bitartrate Capsule
Hydrocodone Bitartrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrocodone Bitartrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydrocodone Bitartrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrocodone Bitartrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydrocodone Bitartrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydrocodone Bitartrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydrocodone Bitartrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 98%
- Above 98%
Applications
- Hydrocodone Bitartrate Oral Solutions
- Hydrocodone Bitartrate Extended-Release Tablets
- Hydrocodone Bitartrate Capsule
Companies covered
- Cambrex
- CNPIC
- Fagron
- Freedom Pharmaceuticals
- Johnson Matthey
- Letco Medical
- Noramco
- Sun Pharma(Chattem Chemicals)
- Temad
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydrocodone Bitartrate Market Size (2021-2032)
- 2.2.2 Global Hydrocodone Bitartrate Sales (2021-2032)
- 2.2.3 Global Hydrocodone Bitartrate Market Average Price (2021-2032)
- 2.3 Hydrocodone Bitartrate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Below 98%
- 2.3.3 Above 98%
- 2.4 Hydrocodone Bitartrate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hydrocodone Bitartrate Oral Solutions
- 2.4.3 Hydrocodone Bitartrate Extended-Release Tablets
- 2.4.4 Hydrocodone Bitartrate Capsule
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydrocodone Bitartrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydrocodone Bitartrate Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Hydrocodone Bitartrate Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydrocodone Bitartrate Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydrocodone Bitartrate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydrocodone Bitartrate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydrocodone Bitartrate, Product Type & Application
- 3.8 Global Manufacturers of Hydrocodone Bitartrate, Established Date
- 3.9 Global Hydrocodone Bitartrate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cambrex
- 4.1.1 Cambrex Company Information
- 4.1.2 Cambrex Business Overview
- 4.1.3 Cambrex Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cambrex Hydrocodone Bitartrate Product Portfolio
- 4.1.5 Cambrex Recent Developments
- 4.2 CNPIC
- 4.2.1 CNPIC Company Information
- 4.2.2 CNPIC Business Overview
- 4.2.3 CNPIC Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CNPIC Hydrocodone Bitartrate Product Portfolio
- 4.2.5 CNPIC Recent Developments
- 4.3 Fagron
- 4.3.1 Fagron Company Information
- 4.3.2 Fagron Business Overview
- 4.3.3 Fagron Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fagron Hydrocodone Bitartrate Product Portfolio
- 4.3.5 Fagron Recent Developments
- 4.4 Freedom Pharmaceuticals
- 4.4.1 Freedom Pharmaceuticals Company Information
- 4.4.2 Freedom Pharmaceuticals Business Overview
- 4.4.3 Freedom Pharmaceuticals Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Freedom Pharmaceuticals Hydrocodone Bitartrate Product Portfolio
- 4.4.5 Freedom Pharmaceuticals Recent Developments
- 4.5 Johnson Matthey
- 4.5.1 Johnson Matthey Company Information
- 4.5.2 Johnson Matthey Business Overview
- 4.5.3 Johnson Matthey Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson Matthey Hydrocodone Bitartrate Product Portfolio
- 4.5.5 Johnson Matthey Recent Developments
- 4.6 Letco Medical
- 4.6.1 Letco Medical Company Information
- 4.6.2 Letco Medical Business Overview
- 4.6.3 Letco Medical Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Letco Medical Hydrocodone Bitartrate Product Portfolio
- 4.6.5 Letco Medical Recent Developments
- 4.7 Noramco
- 4.7.1 Noramco Company Information
- 4.7.2 Noramco Business Overview
- 4.7.3 Noramco Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Noramco Hydrocodone Bitartrate Product Portfolio
- 4.7.5 Noramco Recent Developments
- 4.8 Sun Pharma(Chattem Chemicals)
- 4.8.1 Sun Pharma(Chattem Chemicals) Company Information
- 4.8.2 Sun Pharma(Chattem Chemicals) Business Overview
- 4.8.3 Sun Pharma(Chattem Chemicals) Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma(Chattem Chemicals) Hydrocodone Bitartrate Product Portfolio
- 4.8.5 Sun Pharma(Chattem Chemicals) Recent Developments
- 4.9 Temad
- 4.9.1 Temad Company Information
- 4.9.2 Temad Business Overview
- 4.9.3 Temad Hydrocodone Bitartrate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Temad Hydrocodone Bitartrate Product Portfolio
- 4.9.5 Temad Recent Developments
5 Global Hydrocodone Bitartrate Market Scenario by Region
- 5.1 Global Hydrocodone Bitartrate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydrocodone Bitartrate Sales by Region: 2021-2032
- 5.2.1 Global Hydrocodone Bitartrate Sales by Region: 2021-2026
- 5.2.2 Global Hydrocodone Bitartrate Sales by Region: 2027-2032
- 5.3 Global Hydrocodone Bitartrate Revenue by Region: 2021-2032
- 5.3.1 Global Hydrocodone Bitartrate Revenue by Region: 2021-2026
- 5.3.2 Global Hydrocodone Bitartrate Revenue by Region: 2027-2032
- 5.4 North America Hydrocodone Bitartrate Market Facts & Figures by Country
- 5.4.1 North America Hydrocodone Bitartrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydrocodone Bitartrate Sales by Country (2021-2032)
- 5.4.3 North America Hydrocodone Bitartrate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydrocodone Bitartrate Market Facts & Figures by Country
- 5.5.1 Europe Hydrocodone Bitartrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydrocodone Bitartrate Sales by Country (2021-2032)
- 5.5.3 Europe Hydrocodone Bitartrate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydrocodone Bitartrate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydrocodone Bitartrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydrocodone Bitartrate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydrocodone Bitartrate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydrocodone Bitartrate Market Facts & Figures by Country
- 5.7.1 South America Hydrocodone Bitartrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydrocodone Bitartrate Sales by Country (2021-2032)
- 5.7.3 South America Hydrocodone Bitartrate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydrocodone Bitartrate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydrocodone Bitartrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydrocodone Bitartrate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydrocodone Bitartrate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydrocodone Bitartrate Sales by Type (2021-2032)
- 6.1.1 Global Hydrocodone Bitartrate Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Hydrocodone Bitartrate Sales Market Share by Type (2021-2032)
- 6.2 Global Hydrocodone Bitartrate Revenue by Type (2021-2032)
- 6.2.1 Global Hydrocodone Bitartrate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydrocodone Bitartrate Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydrocodone Bitartrate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydrocodone Bitartrate Sales by Application (2021-2032)
- 7.1.1 Global Hydrocodone Bitartrate Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Hydrocodone Bitartrate Sales Market Share by Application (2021-2032)
- 7.2 Global Hydrocodone Bitartrate Revenue by Application (2021-2032)
- 7.2.1 Global Hydrocodone Bitartrate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydrocodone Bitartrate Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydrocodone Bitartrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydrocodone Bitartrate Value Chain Analysis
- 8.1.1 Hydrocodone Bitartrate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydrocodone Bitartrate Production Mode & Process
- 8.2 Hydrocodone Bitartrate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydrocodone Bitartrate Distributors
- 8.2.3 Hydrocodone Bitartrate Customers
9 Global Hydrocodone Bitartrate Analyzing Market Dynamics
- 9.1 Hydrocodone Bitartrate Industry Trends
- 9.2 Hydrocodone Bitartrate Industry Drivers
- 9.3 Hydrocodone Bitartrate Industry Opportunities and Challenges
- 9.4 Hydrocodone Bitartrate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst